Abionic is a dynamic scale up company based in Switzerland, which is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses the most advanced technology to supply health care professionals with a novel point-of-care diagnostic tool. Abionic therewith gives access to immediate results for various diseases, for example the fastest test for early sepsis detection.
News
Milestones/News
Documents
Videos and Presentations
Discover Abionic's new infrastructures at Biopôle, Switzerland and words from Dr. Nicolas Durand, CEO.
SRF/ECO: Abionic ist einen Schritt weiter
Abionic featured on French TV channel ARTE
TV report from Reuters: Abioscope scratches itch for fast allergy testing
See Abionic on French National TV France3 (only in French)
Abionic featured in the Polytech Ventures movie
Two million Swiss francs for an allergy-detecting device (EPFL movie)
Nicolas Durand presents Abionic (3min)